BPC-157

Clinical Trials

Recovery & Healing

Body Protection Compound derived from gastric juice that accelerates healing of tendons, ligaments, muscles, and gut lining.

Administration

Subcutaneous injection or oral

Dosage Range

250-500 mcg twice daily

Mechanism of Action

BPC-157 upregulates growth factor expression (VEGF, FGF), promotes angiogenesis, modulates nitric oxide synthesis, and activates the FAK-paxillin pathway to accelerate tissue repair at the cellular level.

Clinical Benefits

Accelerates tendon and ligament healing

Protects and heals gut lining

Reduces inflammation systemically

Promotes angiogenesis (new blood vessel formation)

Neuroprotective effects

Clinical Evidence

Extensive preclinical evidence in over 100 animal studies demonstrating wound healing, tendon repair, and gastroprotective effects. Human clinical trials are ongoing for inflammatory bowel conditions.

Side Effects

Mild injection site irritation

Occasional nausea at higher doses

Dizziness (rare)

Contraindications

Active cancer

Pregnancy/breastfeeding

Children under 18

Related Peptides in Recovery & Healing

TB-500 (Thymosin Beta-4)

A naturally occurring peptide that promotes tissue repair, reduces inflammation, and supports cellular migration for wound healing.

Pentadecapeptide (BPC-157 Arginate)

An enhanced oral-stable form of BPC-157 combined with arginine salt for improved bioavailability and systemic healing effects.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Peptide therapy should only be administered under the supervision of a qualified healthcare provider. Always consult your physician before starting any new treatment protocol.